The economic burden of asthma in Italy: evaluating the potential impact of different treatments in adult patients with severe eosinophilic asthma

go back to reference Global Burden of Disease Collaborative Network: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results (2019) Global Burden of Disease Collaborative Network: Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) Results (2019)

go back to reference Masoli, M., Fabian, D., Holt, S., Beasley, R.: The global burden of asthma: executive summary of the GINA Dissemination Committee Report (2004) Masoli, M., Fabian, D., Holt, S., Beasley, R.: The global burden of asthma: executive summary of the GINA Dissemination Committee Report (2004)

go back to reference Cricelli, C., Brignoli, O., Medea, G., Parretti, D., Lombardo, F.P., Aprile, P.L., Lapi, F., Cricelli, I.: Impatto epidemiologico delle cronicità in Medicina Generale Cricelli, C., Brignoli, O., Medea, G., Parretti, D., Lombardo, F.P., Aprile, P.L., Lapi, F., Cricelli, I.: Impatto epidemiologico delle cronicità in Medicina Generale

go back to reference National Asthma Education: Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 120 (2007). https://doi.org/10.1016/j.jaci.2007.09.029 National Asthma Education: Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007. J Allergy Clin Immunol. 120 (2007). https://​doi.​org/​10.​1016/​j.​jaci.​2007.​09.​029

go back to reference GINA: Global Initiative for Asthma—GINA What’s new in GINA 2021? Global Strategy for Asthma Management and Prevention. Ginasthma.org (2021) GINA: Global Initiative for Asthma—GINA What’s new in GINA 2021? Global Strategy for Asthma Management and Prevention. Ginasthma.org (2021)

go back to reference Chung, K.F., Wenzel, S.E., Brozek, J.L., Bush, A., Castro, M., Sterk, P.J., Adcock, I.M., Bateman, E.D., Bel, E.H., Bleecker, E.R., Boulet, L.P., Brightling, C., Chanez, P., Dahlen, S.E., Djukanovic, R., Frey, U., Gaga, M., Gibson, P., Hamid, Q., Jajour, N.N., Mauad, T., Sorkness, R.L., Teague, W.G.: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur. Respir. J. (2014). https://doi.org/10.1183/09031936.00202013CrossRefPubMed Chung, K.F., Wenzel, S.E., Brozek, J.L., Bush, A., Castro, M., Sterk, P.J., Adcock, I.M., Bateman, E.D., Bel, E.H., Bleecker, E.R., Boulet, L.P., Brightling, C., Chanez, P., Dahlen, S.E., Djukanovic, R., Frey, U., Gaga, M., Gibson, P., Hamid, Q., Jajour, N.N., Mauad, T., Sorkness, R.L., Teague, W.G.: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur. Respir. J. (2014). https://​doi.​org/​10.​1183/​09031936.​00202013CrossRefPubMed

go back to reference Micheletto, C., Bilò, M.B., Antonicelli, L., Bresciani, M., D’amato, G., de Benedictis, E., de Michele, F., Gasparini, S., Giovannini, M., Musarra, A., Vaghi, A.: Severe asthma in adolescents and adults: a national, multicenter registry in real life. Eur. Ann. Allergy Clin. Immunol. (2018). https://doi.org/10.23822/EurAnnACI.1764-1489.69CrossRefPubMed Micheletto, C., Bilò, M.B., Antonicelli, L., Bresciani, M., D’amato, G., de Benedictis, E., de Michele, F., Gasparini, S., Giovannini, M., Musarra, A., Vaghi, A.: Severe asthma in adolescents and adults: a national, multicenter registry in real life. Eur. Ann. Allergy Clin. Immunol. (2018). https://​doi.​org/​10.​23822/​EurAnnACI.​1764-1489.​69CrossRefPubMed

go back to reference Bilò, M.B., Antonicelli, L., Carone, M., de Michele, F., Menzella, F., Musarra, A., Tognella, S., Vaghi, A., Micheletto, C.: Severe asthma management in the era of biologics: insights of the italian registry on severe asthma (irsa). Eur. Ann. Allergy Clin. Immunol. (2021). https://doi.org/10.23822/EurAnnACI.1764-1489.196CrossRefPubMed Bilò, M.B., Antonicelli, L., Carone, M., de Michele, F., Menzella, F., Musarra, A., Tognella, S., Vaghi, A., Micheletto, C.: Severe asthma management in the era of biologics: insights of the italian registry on severe asthma (irsa). Eur. Ann. Allergy Clin. Immunol. (2021). https://​doi.​org/​10.​23822/​EurAnnACI.​1764-1489.​196CrossRefPubMed

go back to reference Maio, S., Baldacci, S., Bresciani, M., Simoni, M., Latorre, M., Murgia, N., Spinozzi, F., Braschi, M., Antonicelli, L., Brunetto, B., Iacovacci, P., Roazzi, P., Pini, C., Pata, M., la Grasta, L., Paggiaro, P., Viegi, G., Angino, A., Carrozzi, L., Cerrai, S., di Pede, F., Martini, F., Pala, A.P., Pistelli, F., Sarno, G., Silvi, P., Novelli, F., Ferri, M., Bonifazi, F., Viegi, G.: RItA: The Italian severe/uncontrolled asthma registry. Allergy Eur. J. Allergy Clin. Immunol. (2018). https://doi.org/10.1111/all.13342CrossRef Maio, S., Baldacci, S., Bresciani, M., Simoni, M., Latorre, M., Murgia, N., Spinozzi, F., Braschi, M., Antonicelli, L., Brunetto, B., Iacovacci, P., Roazzi, P., Pini, C., Pata, M., la Grasta, L., Paggiaro, P., Viegi, G., Angino, A., Carrozzi, L., Cerrai, S., di Pede, F., Martini, F., Pala, A.P., Pistelli, F., Sarno, G., Silvi, P., Novelli, F., Ferri, M., Bonifazi, F., Viegi, G.: RItA: The Italian severe/uncontrolled asthma registry. Allergy Eur. J. Allergy Clin. Immunol. (2018). https://​doi.​org/​10.​1111/​all.​13342CrossRef

go back to reference Nagata, M., Nakagome, K., Soma, T.: Mechanisms of eosinophilic inflammation. Asia Pac. Allergy (2020). https://doi.org/10.5415/apallergy.2020.10.e14CrossRefPubMedPubMedCentral Nagata, M., Nakagome, K., Soma, T.: Mechanisms of eosinophilic inflammation. Asia Pac. Allergy (2020). https://​doi.​org/​10.​5415/​apallergy.​2020.​10.​e14CrossRefPubMedPubMedCentral

go back to reference Melo, R.C.N., Weller, P.F.: Contemporary understanding of the secretory granules in human eosinophils (2018) Melo, R.C.N., Weller, P.F.: Contemporary understanding of the secretory granules in human eosinophils (2018)

go back to reference Busse, W.W., Holgate, S.T.: Asthma and Rhinitis. Blackwell Science, New York (2000)CrossRef Busse, W.W., Holgate, S.T.: Asthma and Rhinitis. Blackwell Science, New York (2000)CrossRef

go back to reference Price, D., Wilson, A.M., Chisholm, A., Rigazio, A., Burden, A., Thomas, M., King, C.: Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy (2016). https://doi.org/10.2147/JAA.S97973CrossRefPubMedPubMedCentral Price, D., Wilson, A.M., Chisholm, A., Rigazio, A., Burden, A., Thomas, M., King, C.: Predicting frequent asthma exacerbations using blood eosinophil count and other patient data routinely available in clinical practice. J Asthma Allergy (2016). https://​doi.​org/​10.​2147/​JAA.​S97973CrossRefPubMedPubMedCentral

go back to reference de Groot, J.C., ten Brinke, A., Bel, E.H.D.: Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res. 1, 00024 (2015)CrossRefPubMedPubMedCentral de Groot, J.C., ten Brinke, A., Bel, E.H.D.: Management of the patient with eosinophilic asthma: a new era begins. ERJ Open Res. 1, 00024 (2015)CrossRefPubMedPubMedCentral

go back to reference Loftus, P.A., Wise, S.K.: Epidemiology and economic burden of asthma (2015) Loftus, P.A., Wise, S.K.: Epidemiology and economic burden of asthma (2015)

go back to reference Price, D.B., Trudo, F., Voorham, J., Xu, X., Kerkhof, M., Jie, J.L.Z., Tran, T.N.: Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J. Asthma Allergy (2018). https://doi.org/10.2147/JAA.S176026CrossRefPubMedPubMedCentral Price, D.B., Trudo, F., Voorham, J., Xu, X., Kerkhof, M., Jie, J.L.Z., Tran, T.N.: Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J. Asthma Allergy (2018). https://​doi.​org/​10.​2147/​JAA.​S176026CrossRefPubMedPubMedCentral

go back to reference Sullivan, P.W., Ghushchyan, V.H., Globe, G., Schatz, M.: Oral corticosteroid exposure and adverse effects in asthmatic patients. J. Allergy Clin. Immunol. (2018). https://doi.org/10.1016/j.jaci.2017.04.009CrossRefPubMedPubMedCentral Sullivan, P.W., Ghushchyan, V.H., Globe, G., Schatz, M.: Oral corticosteroid exposure and adverse effects in asthmatic patients. J. Allergy Clin. Immunol. (2018). https://​doi.​org/​10.​1016/​j.​jaci.​2017.​04.​009CrossRefPubMedPubMedCentral

go back to reference Perez-de-Llano, L., Tran, T.N., Al-ahmad, M., Alacqua, M., Bulathsinhala, L., Busby, J., Canonica, G.W., Carter, V., Chaudhry, I., Christoff, G.C., Cosio, B.G., Costello, R.W., Fitzgerald, J.M., Heaney, L.G., Heffler, E., Iwanaga, T., Jackson, D.J., Kerkhof, M., Rhee, C.K., Menzies-Gow, A., Murray, R., Papadopoulos, N.G., Papaioannou, A.L., Pfeffer, P.E., Popov, T.A., Price, C.A., Sadatsafavi, M., Tohda, Y., Wang, E., Wechsler, M., Zangrilli, J.G., Price, D.B.: Characterization of Eosinophilic and Non-Eosinophilic Severe Asthma Phenotypes and Proportion of Patients with These Phenotypes in the International Severe Asthma Registry (ISAR). Presented at the (2020) Perez-de-Llano, L., Tran, T.N., Al-ahmad, M., Alacqua, M., Bulathsinhala, L., Busby, J., Canonica, G.W., Carter, V., Chaudhry, I., Christoff, G.C., Cosio, B.G., Costello, R.W., Fitzgerald, J.M., Heaney, L.G., Heffler, E., Iwanaga, T., Jackson, D.J., Kerkhof, M., Rhee, C.K., Menzies-Gow, A., Murray, R., Papadopoulos, N.G., Papaioannou, A.L., Pfeffer, P.E., Popov, T.A., Price, C.A., Sadatsafavi, M., Tohda, Y., Wang, E., Wechsler, M., Zangrilli, J.G., Price, D.B.: Characterization of Eosinophilic and Non-Eosinophilic Severe Asthma Phenotypes and Proportion of Patients with These Phenotypes in the International Severe Asthma Registry (ISAR). Presented at the (2020)

go back to reference Maio, S., Baldacci, S., Cecchi, L., Viegi, G.: The severe asthma registries: a way to better know and fight the disease. Eur. Ann. Allergy Clin. Immunol. 53, 99 (2021)CrossRefPubMed Maio, S., Baldacci, S., Cecchi, L., Viegi, G.: The severe asthma registries: a way to better know and fight the disease. Eur. Ann. Allergy Clin. Immunol. 53, 99 (2021)CrossRefPubMed

go back to reference Heaney, L.G., Perez de Llano, L., Al-Ahmad, M., Backer, V., Busby, J., Canonica, G.W., Christoff, G.C., Cosio, B.G., FitzGerald, J.M., Heffler, E., Iwanaga, T., Jackson, D.J., Menzies-Gow, A.N., Papadopoulos, N.G., Papaioannou, A.I., Pfeffer, P.E., Popov, T.A., Porsbjerg, C.M., Rhee, C.K., Sadatsafavi, M., Tohda, Y., Wang, E., Wechsler, M.E., Alacqua, M., Altraja, A., Bjermer, L., Björnsdóttir, U.S., Bourdin, A., Brusselle, G.G., Buhl, R., Costello, R.W., Hew, M., Koh, M.S., Lehmann, S., Lehtimäki, L., Peters, M., Taillé, C., Taube, C., Tran, T.N., Zangrilli, J., Bulathsinhala, L., Carter, V.A., Chaudhry, I., Eleangovan, N., Hosseini, N., Kerkhof, M., Murray, R.B., Price, C.A., Price, D.B.: Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort. In: Chest (2021) Heaney, L.G., Perez de Llano, L., Al-Ahmad, M., Backer, V., Busby, J., Canonica, G.W., Christoff, G.C., Cosio, B.G., FitzGerald, J.M., Heffler, E., Iwanaga, T., Jackson, D.J., Menzies-Gow, A.N., Papadopoulos, N.G., Papaioannou, A.I., Pfeffer, P.E., Popov, T.A., Porsbjerg, C.M., Rhee, C.K., Sadatsafavi, M., Tohda, Y., Wang, E., Wechsler, M.E., Alacqua, M., Altraja, A., Bjermer, L., Björnsdóttir, U.S., Bourdin, A., Brusselle, G.G., Buhl, R., Costello, R.W., Hew, M., Koh, M.S., Lehmann, S., Lehtimäki, L., Peters, M., Taillé, C., Taube, C., Tran, T.N., Zangrilli, J., Bulathsinhala, L., Carter, V.A., Chaudhry, I., Eleangovan, N., Hosseini, N., Kerkhof, M., Murray, R.B., Price, C.A., Price, D.B.: Eosinophilic and noneosinophilic asthma: an expert consensus framework to characterize phenotypes in a global real-life severe asthma cohort. In: Chest (2021)

go back to reference Wilson, E.B.: Probable inference, the law of succession, and statistical inference. J. Am. Stat. Assoc. (1927). https://doi.org/10.2307/2276774CrossRef Wilson, E.B.: Probable inference, the law of succession, and statistical inference. J. Am. Stat. Assoc. (1927). https://​doi.​org/​10.​2307/​2276774CrossRef

go back to reference Johnson, R.W.: An introduction to the bootstrap. Teach. Stat. (2001). https://doi.org/10.1111/1467-9639.00050CrossRef Johnson, R.W.: An introduction to the bootstrap. Teach. Stat. (2001). https://​doi.​org/​10.​1111/​1467-9639.​00050CrossRef

go back to reference Vultaggio, A., Aliani, M., Altieri, E., Bracciale, P., Brussino, L., Caiaffa, M.F., Cameli, P., Canonica, G.W., Caruso, C., Centanni, S., D’Amato, M., De Michele, F., Del Giacco, S., Di Marco, F., Menzella, F., Pelaia, G., Rogliani, P., Romagnoli, M., Schino, P., Senna, G., Benci, M., Boarino, S., Schroeder, J.W.: Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study. Respir. Res. 24, 135 (2023). https://doi.org/10.1186/s12931-023-02439-wCrossRefPubMedPubMedCentral Vultaggio, A., Aliani, M., Altieri, E., Bracciale, P., Brussino, L., Caiaffa, M.F., Cameli, P., Canonica, G.W., Caruso, C., Centanni, S., D’Amato, M., De Michele, F., Del Giacco, S., Di Marco, F., Menzella, F., Pelaia, G., Rogliani, P., Romagnoli, M., Schino, P., Senna, G., Benci, M., Boarino, S., Schroeder, J.W.: Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study. Respir. Res. 24, 135 (2023). https://​doi.​org/​10.​1186/​s12931-023-02439-wCrossRefPubMedPubMedCentral

go back to reference Dal Negro, R.W., Micheletto, C., Tosatto, R., Dionisi, M., Turco, P., Donner, C.F.: Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study. Respir. Med. (2007). https://doi.org/10.1016/j.rmed.2007.07.011CrossRef Dal Negro, R.W., Micheletto, C., Tosatto, R., Dionisi, M., Turco, P., Donner, C.F.: Costs of asthma in Italy: results of the SIRIO (Social Impact of Respiratory Integrated Outcomes) study. Respir. Med. (2007). https://​doi.​org/​10.​1016/​j.​rmed.​2007.​07.​011CrossRef

go back to reference Nurmagambetov, T., Kuwahara, R., Garbe, P.: The economic burden of asthma in the United States, 2008–2013. Ann. Am. Thorac. Soc. (2018). https://doi.org/10.1513/AnnalsATS.201703-259OCCrossRefPubMed Nurmagambetov, T., Kuwahara, R., Garbe, P.: The economic burden of asthma in the United States, 2008–2013. Ann. Am. Thorac. Soc. (2018). https://​doi.​org/​10.​1513/​AnnalsATS.​201703-259OCCrossRefPubMed

go back to reference Vitale, C., Maglio, A., Pelaia, C., D’Amato, M., Ciampo, L., Pelaia, G., Molino, A., Vatrella, A.: Effectiveness of benralizumab in OCS-dependent severe asthma: the impact of 2 years of therapy in a real-life setting. J. Clin. Med. (2023). https://doi.org/10.3390/jcm12030985CrossRefPubMedPubMedCentral Vitale, C., Maglio, A., Pelaia, C., D’Amato, M., Ciampo, L., Pelaia, G., Molino, A., Vatrella, A.: Effectiveness of benralizumab in OCS-dependent severe asthma: the impact of 2 years of therapy in a real-life setting. J. Clin. Med. (2023). https://​doi.​org/​10.​3390/​jcm12030985CrossRefPubMedPubMedCentral

go back to reference Sposato, B., Scalese, M., Camiciottoli, G., Carpagnano, G.E., Pelaia, C., Santus, P., Pelaia, G., Palmiero, G., Tomassi, M.D.I., Ronchi, M.C., Cameli, P., Bargagli, E., Ciambellotti, L., Rizzello, S., Sglavo, R., Coppola, A., Lacerenza, L.G., Gabriele, M., Radovanovic, D., Perrella, A., Ricci, A., Rogliani, P.: Severe asthma and long-term Benralizumab effectiveness in real-life. Eur. Rev. Med. Pharmacol. Sci. (2022). https://doi.org/10.26355/eurrev_202210_30016CrossRefPubMed Sposato, B., Scalese, M., Camiciottoli, G., Carpagnano, G.E., Pelaia, C., Santus, P., Pelaia, G., Palmiero, G., Tomassi, M.D.I., Ronchi, M.C., Cameli, P., Bargagli, E., Ciambellotti, L., Rizzello, S., Sglavo, R., Coppola, A., Lacerenza, L.G., Gabriele, M., Radovanovic, D., Perrella, A., Ricci, A., Rogliani, P.: Severe asthma and long-term Benralizumab effectiveness in real-life. Eur. Rev. Med. Pharmacol. Sci. (2022). https://​doi.​org/​10.​26355/​eurrev_​202210_​30016CrossRefPubMed

go back to reference Azzano, P., Dufresne, É., Poder, T., Bégin, P.: Economic considerations on the usage of biologics in the allergy clinic. Allergy 76, 191–209 (2021)CrossRefPubMed Azzano, P., Dufresne, É., Poder, T., Bégin, P.: Economic considerations on the usage of biologics in the allergy clinic. Allergy 76, 191–209 (2021)CrossRefPubMed

go back to reference Reibman, J., Tan, L., Ambrose, C., Chung, Y., Desai, P., Llanos, J.P., Moynihan, M., Tkacz, J.: Clinical and economic burden of severe asthma among US patients treated with biologic therapies. Ann. Allergy Asthma Immunol.Immunol. 127, 4589 (2021) Reibman, J., Tan, L., Ambrose, C., Chung, Y., Desai, P., Llanos, J.P., Moynihan, M., Tkacz, J.: Clinical and economic burden of severe asthma among US patients treated with biologic therapies. Ann. Allergy Asthma Immunol.Immunol. 127, 4589 (2021)